Isophane Protamine Human Insulin（50R）(Novo Nordisk )

精蛋白人胰岛素混合注射液（50R)（诺和诺德）

Report date: 2022/01/27 13:31:46

Base Information

Drug NameIsophane Protamine Human Insulin（50R）(Novo Nordisk )
Drug Alias Name精蛋白人胰岛素混合注射液（50R)诺和灵50R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2019/11/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A